Why Test for Loa loa Before River Blindness Treatment?
At a Glance
Testing for Loa loa before treating river blindness is a critical safety step. If you have a high number of Loa loa parasites in your blood, taking ivermectin can trigger a massive inflammatory response causing severe brain swelling. This test ensures the medication is safe to take.
It is understandable to feel frustrated when you are ready to start treatment for river blindness (onchocerciasis) but are told you must wait for another test first. Your doctor is testing you for Loa loa, also known as the African eye worm, because taking the standard river blindness medication (ivermectin) while you have a high number of Loa loa parasites in your blood can cause severe, life-threatening complications.
The Danger of Treating Both Parasites at Once
River blindness and Loa loa are both caused by parasitic worms that are common in parts of Central and West Africa. Because these parasites share similar geographic regions, it is common for a person to be infected with both at the same time.
The most effective treatment for river blindness is a medication called ivermectin. However, ivermectin also rapidly kills the microscopic baby worms (microfilariae) of the Loa loa parasite [1][2]. If you have a massive number of Loa loa microfilariae in your blood—typically more than 30,000 per milliliter—and you take ivermectin, the sudden death of all those parasites triggers an overwhelming inflammatory reaction in your body [3][4][2].
This massive reaction can block the tiny blood vessels in your brain and damage the blood-brain barrier [5][6]. This leads to a severe neurological condition called encephalopathy (swelling and damage to the brain), which can cause confusion, extreme lethargy, coma, and can even be fatal [3][7].
The “Test-and-Not-Treat” Safety Protocol
Because the risk of encephalopathy is so serious, health organizations have established strict screening protocols for anyone from regions where Loa loa is found [8][9]. Doctors must verify that your blood is safe before giving you ivermectin.
To check your risk, your care team will test a small sample of your blood to count the number of Loa loa microfilariae [10][3]. This is often done using a rapid, specialized microscope tool called a LoaScope [10][8]. The LoaScope can provide results in just a few minutes. Even if your clinic uses a standard laboratory test that takes a few days, this short delay will not permanently worsen your vision.
Based on your test results, your doctor will determine the safest path forward:
- Low or Zero Loa loa Levels: If your blood has very few or no Loa loa parasites, it is generally safe to proceed with standard ivermectin treatment for river blindness.
- High Loa loa Levels: If your parasite count is dangerously high, your doctor will withhold ivermectin [8][9]. Instead, they may recommend a medication like albendazole to slowly lower your Loa loa levels so ivermectin can be used safely later [11][12]. They might also prescribe a multi-week course of antibiotics (like doxycycline), which treats river blindness by targeting bacteria the worms need to survive, without triggering a severe Loa loa reaction.
Testing for Loa loa is not an unnecessary delay; it is a critical, mandatory safety step to ensure the treatment meant to protect your vision does not put your life at risk.
Common questions in this guide
Why can't I just take ivermectin for river blindness immediately?
What happens if my Loa loa parasite count is too high for ivermectin?
How is the test for the African eye worm performed?
What are the signs that I might have a Loa loa infection?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How quickly will we get the results of my Loa loa test back?
- 2.What safe, temporary options do I have to relieve my severe itching or eye discomfort while we wait for the test results?
- 3.If my Loa loa levels are too high for ivermectin, which alternative treatment path (like albendazole or doxycycline) would be best for my situation?
- 4.What symptoms should prompt me to go to the emergency room while I wait for treatment?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Encephalopathy in a patient with loiasis treated with albendazole: A case report.
Volpicelli L, De Angelis M, Morano A, et al.
Parasitology international 2020; (75()):102006 doi:10.1016/j.parint.2019.102006.
PMID: 31676328 - 2
Albendazole-related Loa Loa encephalopathy.
Métais A, Michalak S, Rousseau A
IDCases 2021; (23()):e01033 doi:10.1016/j.idcr.2020.e01033.
PMID: 33489754 - 3
A novel antigen biomarker for detection of high-level of Loa loa microfilaremia.
Greene SE, Huang Y, Fischer K, et al.
PLoS neglected tropical diseases 2024; (18(9)):e0012461 doi:10.1371/journal.pntd.0012461.
PMID: 39226306 - 4
Central and Peripheral Nervous System Disorders Following Ivermectin Mass Administration: A Descriptive Study Based on the Democratic Republic of Congo Pharmacovigilance System.
Nzolo D, Anto F, Hailemariam S, et al.
Drugs - real world outcomes 2017; (4(3)):151-158 doi:10.1007/s40801-017-0110-0.
PMID: 28600751 - 5
Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.
Wanji S, Eyong EJ, Tendongfor N, et al.
PLoS neglected tropical diseases 2017; (11(7)):e0005576 doi:10.1371/journal.pntd.0005576.
PMID: 28686693 - 6
Inflammation and hemostasis in loiasis before and after ivermectin treatment: A biological pilot cross-sectional study.
Lepage TM, Nzune-Toche N, Nkwengoua LA, et al.
PLoS neglected tropical diseases 2024; (18(12)):e0012491 doi:10.1371/journal.pntd.0012491.
PMID: 39680571 - 7
Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo.
Makenga Bof JC, Muteba D, Mansiangi P, et al.
BMC pharmacology & toxicology 2019; (20(1)):49 doi:10.1186/s40360-019-0327-5.
PMID: 31420005 - 8
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon.
Lenk EJ, Moungui HC, Boussinesq M, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (70(8)):1628-1635 doi:10.1093/cid/ciz461.
PMID: 31165855 - 9
Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Pion SD, Nana-Djeunga H, Niamsi-Emalio Y, et al.
The Lancet. Infectious diseases 2020; (20(1)):102-109 doi:10.1016/S1473-3099(19)30554-7.
PMID: 31676244 - 10
Colorimetric and Real-Time Loop-Mediated Isothermal Amplification (LAMP) for Detection of Loa loa DNA in Human Blood Samples.
Febrer-Sendra B, Fernández-Soto P, Crego-Vicente B, et al.
Diagnostics (Basel, Switzerland) 2022; (12(5)) doi:10.3390/diagnostics12051079.
PMID: 35626235 - 11
Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial.
Chesnais CB, Hemilembolo MC, Sahm BA, et al.
Nature communications 2025; (16(1)):6191 doi:10.1038/s41467-025-61479-6.
PMID: 40615414 - 12
Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial.
Campillo JT, Bikita P, Hemilembolo M, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (75(1)):19-27 doi:10.1093/cid/ciab906.
PMID: 34651190
This page explains the medical reasoning for Loa loa screening prior to river blindness treatment for educational purposes. Always consult your tropical medicine specialist or healthcare provider regarding parasitic infection testing and treatment protocols.
Get notified when new evidence is published on Onchocerciasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.